MCP
TARO
Moab Capital Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-30,007
| Closed | -$4.3M | – | 31 |
|
|
2016
Q1 | $4.3M | Buy |
30,007
+802
| +3% | +$115K | 1.5% | 15 |
|
|
2015
Q4 | $4.51M | Sell |
29,205
-80,482
| -73% | -$12.4M | 1.6% | 16 |
|
|
2015
Q3 | $15.7M | Buy |
109,687
+8,006
| +8% | +$1.14M | 5.51% | 5 |
|
|
2015
Q2 | $14.6M | Buy |
101,681
+24,724
| +32% | +$3.55M | 4.37% | 5 |
|
|
2015
Q1 | $10.9M | Sell |
76,957
-2,600
| -3% | -$367K | 3.53% | 6 |
|
|
2014
Q4 | $11.8M | Buy |
79,557
+16,137
| +25% | +$2.39M | 4.65% | 5 |
|
|
2014
Q3 | $9.76M | Sell |
63,420
-29,713
| -32% | -$4.57M | 3.63% | 10 |
|
|
2014
Q2 | $13.1M | Sell |
93,133
-300
| -0.3% | -$42.1K | 6.27% | 4 |
|
|
2014
Q1 | $10.4M | Buy |
93,433
+10,301
| +12% | +$1.14M | 4.54% | 7 |
|
|
2013
Q4 | $8.22M | Sell |
83,132
-3,178
| -4% | -$314K | 3.77% | 8 |
|
|
2013
Q3 | $6.56M | Buy |
86,310
+32,000
| +59% | +$2.43M | 3.9% | 10 |
|
|
2013
Q2 | $3.04M | Buy |
+54,310
| New | +$3.04M | 1.82% | 16 |
|